Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126005 · ClinicalTrials.gov registry record
Natural History Study of Patients With Canavan Disease (CANinform Study)
A clinical trial of Canavan Disease, sponsored by Aspa Therapeutics.
- Active
- Registry status
- 70
- Enrollment target
- 3
- Study locations
NCT04126005 is a study of Canavan Disease that is active but no longer recruiting, run by Aspa Therapeutics. The registered enrollment target is 70 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT04126005, a study of Canavan Disease, is active but no longer recruiting, sponsored by Aspa Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study uses medical records that allow retrospective data extraction of critical milestone and motor function data. In addition, prospective assessments collect data relevant to the natural history of Canavan disease in children.
Conditions Studied
Study Locations (3)
California
- UCSF Benioff Children's Hospital Oakland - Oakland
Massachusetts
- Massachusetts General Hospital - Boston
Other
- University Medical Center Hamburg-Eppendorf - Hamburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126005
The ClinicalTrials.gov registry entry for NCT04126005 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aspa Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Canavan Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04126005 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT04126005 about?
NCT04126005 is a clinical study titled "Natural History Study of Patients With Canavan Disease (CANinform Study)". This study uses medical records that allow retrospective data extraction of critical milestone and motor function data. In addition, prospective assessments collect data relevant to the natural history of Canavan disease in children.
What is the current status of trial NCT04126005?
This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2019-10-10. Estimated completion is 2025-07-31.
What conditions does trial NCT04126005 study?
This clinical trial studies the following conditions: Canavan Disease.
Who is sponsoring clinical trial NCT04126005?
This trial is sponsored by Aspa Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126005 being conducted?
This trial has 3 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Canavan Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.